Mechanism: Multi-System Weight Loss Semaglutide is a modified analog of human GLP-1, the incretin hormone released by intestinal L-cells after eating
Modified Irvine, Beatties and Bresnahan forelimb scale (IBB scale, scored 02, 03, 01) (63, 64) for assessment of forelimb function impairment in rats that received cuprizone diet, and then cuprizone intragastrical applications, and thereby, cuprizone toxicity manifestations
The absolute risk increase for diabetic retinopathy complications was greater among patients with a history of diabetic retinopathy at baseline (semaglutide 8.2%, placebo 5.2%) than among patients without a known history of diabetic retinopathy (semaglutide 0.7%, placebo 0.4%)
This concentration is widely accepted in medicine
(PubMed) Simon JA, Hudes ES
It does not constitute medical advice, a diagnosis, or a treatment recommendation